Nexplanon does not have an official weight limit. There is no specific number on the scale that disqualifies you from getting the implant. However, the original clinical trials excluded women who weighed more than 130% of their ideal body weight, which means the evidence base for higher-weight users has historically been thinner than for other groups. That gap has narrowed considerably as newer studies have examined how well the implant works across a wider range of body sizes.
What the Clinical Trials Originally Tested
When Nexplanon was first approved, the manufacturer’s trials left out women above 130% of their ideal body weight. That exclusion wasn’t because researchers found the implant didn’t work at higher weights. It was a common study design choice at the time, and it left a genuine question mark that the FDA prescribing information still acknowledges. The label notes a lack of direct evidence in users with overweight and obesity and suggests that providers “consider” earlier replacement in these groups.
Since then, researchers have specifically studied this question. A pharmacokinetics trial included 215 women with a median BMI of 27.9, and the group included 86 women with a BMI of 30 or higher and 23 with a BMI of 40 or higher. That’s a meaningful sample of people the original trials would have excluded.
How Weight Affects Hormone Levels
The implant works by steadily releasing a synthetic hormone into your bloodstream that prevents ovulation. In women with a higher body weight, blood concentrations of that hormone run lower, roughly 31 to 63% lower than in normal-weight women during the first six months. That sounds alarming on its own, but the picture is more nuanced than the percentage suggests.
The key question isn’t whether levels are lower in a relative sense. It’s whether they drop below the threshold needed to actually prevent ovulation. In the extended-use trial that followed women from years 3 through 5, women with a BMI of 30 or higher had hormone concentrations ranging from about 50 to 455 pg/mL at the five-year mark. Women under a BMI of 30 ranged from 33 to 363 pg/mL. Those ranges overlap substantially, and both stayed in the territory associated with ovulation suppression. Even at year five, two full years past the approved duration, hormone levels in higher-BMI users remained sufficient.
Does It Actually Work Less Well at Higher Weights?
A systematic review published in BMJ Sexual & Reproductive Health looked at all available studies on implant effectiveness in users with overweight and obesity. The conclusion: the observed effectiveness in these groups falls within the same range reported across all weight categories, between 0.0 and 1.4 pregnancies per 100 woman-years. The reviewers found “no indication for relevant differences in the effectiveness of the implant with respect to user weight” through the standard three-year duration.
That failure rate is still remarkably low. For context, it makes the implant one of the most effective contraceptive methods available regardless of body size. The real-world pregnancy rate stays well under 1% per year even in higher-weight users.
Whether You Need to Replace It Earlier
The prescribing information suggests providers consider earlier replacement for users with higher body weight, but this recommendation stems from the original data gap rather than from evidence of actual failures. The systematic review found no support for reduced effectiveness through the full three-year approved duration. Separately, research has shown that hormone concentrations remain high enough to suppress ovulation beyond three years regardless of BMI.
If your provider brings up the idea of replacing the implant before the three-year mark, it’s worth knowing that the most current evidence doesn’t strongly support that approach. Nexplanon is now FDA-approved for up to five years of use, and the extended-use trial specifically included women with BMIs above 30 and above 40. That said, some providers still take a cautious approach based on the label language, and having this conversation with your provider is reasonable.
Why the Implant Holds Up Better Than Other Methods
Other hormonal contraceptives, particularly the pill and the patch, show more noticeable drops in effectiveness at higher body weights. The implant is different because it delivers hormone continuously and directly into the bloodstream rather than relying on absorption through the gut or skin. Even though blood concentrations are relatively lower in higher-weight users, the implant maintains levels above the ovulation-suppression threshold for years. It doesn’t depend on daily timing or consistent absorption the way oral or transdermal methods do, which is part of why its real-world effectiveness stays so high across body sizes.